Breaking News Instant updates and real-time market news.

OMER

Omeros

$7.50

-0.1 (-1.32%)

07:04
10/19/16
10/19
07:04
10/19/16
07:04

Omeros says PPAR-gamma agonist decreased craving in patients with CUD

Omeros announced results from a Phase 2 clinical trial evaluating the effects of a peroxisome proliferator-activated receptor-gamma agonist in patients with cocaine use disorder. The trial, designed and conducted by Joy M. Schmitz, Ph.D. and her colleagues at the Center for Neurobehavioral Research on Addiction, University of Texas Health Science Center - Houston, demonstrates that the PPAR-gamma agonist reduces craving and improves the integrity of brain white matter in patients with CUD. There currently are no approved medications to treat cocaine addiction. Omeros' issued and pending patents in its OMS405 program cover the use of any PPAR-gamma agonist, alone or in combination with other addiction therapies, to treat all forms of addiction, including cocaine, nicotine, opioids, alcohol and other substances of abuse as well as addictive or compulsive behaviors. In this double-blind, placebo-controlled Phase 2 clinical trial, 30 treatment-seeking CUD patients were randomized to receive either a PPAR-gamma agonist or placebo daily for 12 weeks. Measures of impulsivity, decision-making and cocaine craving were recorded at multiple time points. A subgroup of 19 patients underwent brain scans using diffusion tensor imaging to measure white matter integrity before and after the course of treatment. The data reveal a statistically significant time-dependent reduction in cocaine craving in PPAR-gamma-agonist-treated patients compared to placebo controls. Treated patients also showed improvement in white matter integrity in four target DTI regions of interest, specifically in the corpus callosum and in two associated thalamic tracts. During treatment, side effects reported were minimal and similar between the PPAR-gamma agonist and placebo groups. These clinical findings are consistent with results of earlier mechanistic and target-based preclinical studies showing that PPAR-gamma agonists protect against neuronal damage and block reinstatement of cocaine, heroin and alcohol seeking in animal models of drug abuse.

OMER Omeros
$7.50

-0.1 (-1.32%)

06/02/16
CANT
06/02/16
INITIATION
Target $21
CANT
Buy
Omeros initiated with a Buy at Cantor
Target $21.

TODAY'S FREE FLY STORIES

SIEGY

Siemens

$70.08

-0.19 (-0.27%)

, BDRBF

Bombardier

$1.83

-0.0236 (-1.27%)

15:02
06/28/17
06/28
15:02
06/28/17
15:02
Periodicals
Breaking Periodicals news story on Siemens, Bombardier »

Siemens, Bombardier…

SIEGY

Siemens

$70.08

-0.19 (-0.27%)

BDRBF

Bombardier

$1.83

-0.0236 (-1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

T

AT&T

$37.89

0.186 (0.49%)

15:00
06/28/17
06/28
15:00
06/28/17
15:00
Options
AT&T attracts downside put buyers »

AT&T attracts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POT

Potash

$16.34

-0.015 (-0.09%)

14:55
06/28/17
06/28
14:55
06/28/17
14:55
Options
Potash put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARA

Cara Therapeutics

$26.42

1.01 (3.97%)

, NKTR

Nektar

$18.82

-0.915 (-4.64%)

14:46
06/28/17
06/28
14:46
06/28/17
14:46
Hot Stocks
Before the Move: Watch Cara Therapeutics into osteoarthritis pain results »

Cara Therapeutics (CARA)…

CARA

Cara Therapeutics

$26.42

1.01 (3.97%)

NKTR

Nektar

$18.82

-0.915 (-4.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

NRG

NRG Energy

$17.41

0.2001 (1.16%)

14:45
06/28/17
06/28
14:45
06/28/17
14:45
Options
NRG Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDEN

Golden Entertainment

$20.36

-0.37 (-1.78%)

14:43
06/28/17
06/28
14:43
06/28/17
14:43
Hot Stocks
Golden Entertainment announces approval for Illinois gaming terminal license »

Golden Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

Labarge

$54.33

-0.085 (-0.16%)

14:30
06/28/17
06/28
14:30
06/28/17
14:30
Options
6X average daily volume in L Brands driven by a three-way spread »

6X average daily volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENX

Fenix Parts

$1.57

0.08 (5.37%)

14:29
06/28/17
06/28
14:29
06/28/17
14:29
Hot Stocks
Fenix Parts plunges after Nasdaq delisting notice »

Shares of microcap Fenix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HL

Hecla Mining

$5.25

0.075 (1.45%)

14:28
06/28/17
06/28
14:28
06/28/17
14:28
Hot Stocks
Breaking Hot Stocks news story on Hecla Mining »

Hecla Mining trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPH

KemPharm

$3.45

0.05 (1.47%)

14:25
06/28/17
06/28
14:25
06/28/17
14:25
Conference/Events
KemPharm to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

HL

Hecla Mining

$5.25

0.075 (1.45%)

14:24
06/28/17
06/28
14:24
06/28/17
14:24
Earnings
Hecla Mining sees Q2 revenue of $127M-$137M, consensus $145.85M »

Hecla Mining announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HL

Hecla Mining

$5.25

0.075 (1.45%)

14:21
06/28/17
06/28
14:21
06/28/17
14:21
Hot Stocks
Hecla Mining to offer $500M of senior notes »

Hecla Mining announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVA

Sinovac Biotech

$6.34

-0.07 (-1.09%)

14:20
06/28/17
06/28
14:20
06/28/17
14:20
Hot Stocks
Sinobioway Consortium confirms Sinovac Biotech offer raised to $8 per share »

Shandong Sinobioway…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
06/28/17
06/28
14:17
06/28/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
06/28/17
06/28
14:16
06/28/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

PowerShares QQQ Trust

$138.03

-2.55 (-1.81%)

14:10
06/28/17
06/28
14:10
06/28/17
14:10
Options
Defensive option play in the PowerShares QQQ »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGX

Argan

$62.40

0.9 (1.46%)

14:08
06/28/17
06/28
14:08
06/28/17
14:08
Initiation
Argan initiated  »

Argan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HL

Hecla Mining

$5.24

0.07 (1.35%)

14:05
06/28/17
06/28
14:05
06/28/17
14:05
Hot Stocks
Breaking Hot Stocks news story on Hecla Mining »

Hecla Mining trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
06/28/17
06/28
14:05
06/28/17
14:05
General news
U.S. equities are extending their bull run »

U.S. equities are…

14:00
06/28/17
06/28
14:00
06/28/17
14:00
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

13:58
06/28/17
06/28
13:58
06/28/17
13:58
General news
Averages, internals remain strong in afternoon trading »

Stocks remain sharply…

13:55
06/28/17
06/28
13:55
06/28/17
13:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Financial…

KKR

KKR

$18.59

0.385 (2.12%)

13:52
06/28/17
06/28
13:52
06/28/17
13:52
Periodicals
KKR sells entire Visma stake for GBP1.4B, FT reports »

KKR has sold the entirety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$362.37

-15.12 (-4.01%)

, BAMXY

BMW Group

13:44
06/28/17
06/28
13:44
06/28/17
13:44
Periodicals
BMW takes aim at Tesla with upcoming electric sedan, Handelsblatt says »

At Germany's premier…

TSLA

Tesla

$362.37

-15.12 (-4.01%)

BAMXY

BMW Group

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

KS

KapStone

$21.04

0.6 (2.94%)

, PKG

Packaging Corp.

$112.98

2.37 (2.14%)

13:44
06/28/17
06/28
13:44
06/28/17
13:44
Recommendations
BMO says Packaging has 'dry powder,' unlikely to buy KapStone »

After spending time with…

KS

KapStone

$21.04

0.6 (2.94%)

PKG

Packaging Corp.

$112.98

2.37 (2.14%)

UFS

Domtar

$38.97

1.86 (5.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 27

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.